ASMB
ASSEMBLY BIOSCIENCES, INC.
NASDAQ · Healthcare · Biotechnology · US
$24.97
−1.46%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.66
- Revenue estimate
- $9.1M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.72
- Revenue actual
- $13.4M
- Revenue estimate
- $8.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +145.3%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $49
- PT range
- $45 – $52
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.72 | -$0.20 | Beat 72.38% | $13.4M |
| May 7, 2026 | -$0.73 | -$0.54 | Beat 26.03% | $8.2M |
| Mar 19, 2026 | -$0.51 | $2.48 | Beat 586.27% | $42.5M |
| Aug 6, 2025 | -$0.65 | -$1.33 | Miss -103.57% | $9.6M |
| May 8, 2025 | -$2.01 | -$1.17 | Beat 41.79% | $9.4M |
| Mar 20, 2025 | -$1.75 | -$1.57 | Beat 10.29% | $7.4M |
| Nov 7, 2024 | -$2.02 | -$1.51 | Beat 25.25% | $6.8M |
| Aug 8, 2024 | -$2.96 | -$1.98 | Beat 33.11% | $8.5M |
| May 8, 2024 | -$2.74 | -$1.66 | Beat 39.42% | $5.8M |
| May 4, 2023 | -$4.44 | -$4.44 | In line | — |
| Mar 22, 2023 | -$6.72 | -$5.52 | Beat 17.86% | — |
| May 12, 2022 | -$5.88 | -$5.76 | Beat 2.04% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026